Ziruoyu Wang

机构：Dalian Medical University, Fudan University, Second Affiliated Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-9418-5725

发表论文 9 篇 · 总被引 131 次 · h-index 5

代表论文

• Targets of tumor microenvironment for potential drug development (2024 · MedComm – Oncology · 被引 54)
• Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells (2023 · Signal Transduction and Targeted Therapy · 被引 38)
• Natural product P57 induces hypothermia through targeting pyridoxal kinase (2023 · Nature Communications · 被引 14)
• P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression (2024 · Leukemia · 被引 13)
• A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells (2022 · Genes & Diseases · 被引 10)
• Microtubule dynamics is a therapeutic vulnerability in VHL-deficient renal cell carcinoma (2025 · International Journal of Biological Sciences · 被引 3)